• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RANKL 是否是骨关节炎的潜在分子靶点?

Is RANKL a potential molecular target in osteoarthritis?

机构信息

Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, South Australia 5000, Australia; Biomedical Orthopaedic Research Group, Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, South Australia 5000, Australia.

Centre for Orthopaedic & Trauma Research, The University of Adelaide, Adelaide, South Australia 5000, Australia.

出版信息

Osteoarthritis Cartilage. 2024 May;32(5):493-500. doi: 10.1016/j.joca.2023.10.010. Epub 2023 Dec 30.

DOI:10.1016/j.joca.2023.10.010
PMID:38160744
Abstract

OBJECTIVE

Osteoarthritis (OA) is a disease of joints, in which the bone under the articular cartilage undergoes increased remodelling activity. The question is whether a better understanding of the causes and mechanisms of bone remodelling can predict disease-modifying treatments.

DESIGN

This review summarises the current understanding of the aetiology of OA, with an emphasis on events in the subchondral bone (SCB), and the cells and cytokines involved, to seek an answer to this question.

RESULTS

SCB remodelling across OA changes the microstructure of the SCB, which alters the load-bearing properties of the joint and seems to have an important role in the initiation and progression of OA. Bone remodelling is tightly controlled by numerous cytokines, of which Receptor Activator of NFκB ligand (RANKL) and osteoprotegerin are central factors in almost all known bone conditions. In terms of finding therapeutic options for OA, an important question is whether controlling the rate of SCB remodelling would be beneficial. The role of RANKL in the pathogenesis and progression of OA and the effect of its neutralisation remain to be clarified.

CONCLUSIONS

This review further makes the case for SCB remodelling as important in OA and for additional study of RANKL in OA, both its pathophysiological role and its potential as an OA disease target.

摘要

目的

骨关节炎(OA)是一种关节疾病,其中关节软骨下的骨经历了增强的重塑活动。问题是,对骨重塑的原因和机制的更好理解是否可以预测疾病修饰治疗。

设计

本综述总结了 OA 病因学的当前理解,重点是软骨下骨(SCB)中的事件以及涉及的细胞和细胞因子,以寻求对这个问题的答案。

结果

OA 中 SCB 重塑改变了 SCB 的微观结构,这改变了关节的承载性能,并且似乎在 OA 的起始和进展中具有重要作用。骨重塑受众多细胞因子的紧密控制,其中核因子κB 配体(RANKL)和骨保护素是几乎所有已知骨病的核心因素。就 OA 的治疗选择而言,一个重要的问题是控制 SCB 重塑的速度是否有益。RANKL 在 OA 的发病机制和进展中的作用及其中和作用仍有待阐明。

结论

本综述进一步证明了 SCB 重塑在 OA 中的重要性,以及对 RANKL 在 OA 中的进一步研究,包括其病理生理学作用及其作为 OA 疾病靶点的潜力。

相似文献

1
Is RANKL a potential molecular target in osteoarthritis?RANKL 是否是骨关节炎的潜在分子靶点?
Osteoarthritis Cartilage. 2024 May;32(5):493-500. doi: 10.1016/j.joca.2023.10.010. Epub 2023 Dec 30.
2
The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.人骨关节炎软骨下骨成骨细胞中骨保护素(OPG)和核因子κB受体激活剂配体(RANKL)的差异表达是这些疾病细胞代谢状态的一个指标。
Clin Exp Rheumatol. 2008 Mar-Apr;26(2):295-304.
3
The expression of RANKL and OPG in the various grades of osteoarthritic cartilage.在不同等级骨关节炎软骨中 RANKL 和 OPG 的表达。
Rheumatol Int. 2012 Feb;32(2):535-40. doi: 10.1007/s00296-010-1733-6. Epub 2011 Jan 23.
4
Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits.帕米膦酸二钠对兔骨关节炎软骨下骨丢失及软骨和软骨下骨护骨素与核因子κB受体活化因子配体表达的影响
BMC Musculoskelet Disord. 2014 Nov 6;15:370. doi: 10.1186/1471-2474-15-370.
5
Teriparatide ameliorates articular cartilage degradation and aberrant subchondral bone remodeling in DMM mice.特立帕肽可改善去卵巢内侧半月板不稳定(DMM)小鼠的关节软骨退变和异常的软骨下骨重塑。
J Orthop Translat. 2022 Dec 7;38:241-255. doi: 10.1016/j.jot.2022.10.015. eCollection 2023 Jan.
6
Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis.改善软骨下骨完整性可减少骨质疏松症前期实验性骨关节炎软骨损伤的进展。
Osteoarthritis Cartilage. 2011 Oct;19(10):1228-36. doi: 10.1016/j.joca.2011.07.003. Epub 2011 Jul 23.
7
[Experimental study on the regulation of subchondral bone plate osteoprotegerin/receptor activator of nuclear factor kappa-B ligand system by berberine to retard the development of osteoarthritis in rabbits].黄连素调控软骨下骨板骨保护素/核因子κB受体活化因子配体系统延缓兔骨关节炎发展的实验研究
Zhongguo Gu Shang. 2022 May 25;35(5):464-9. doi: 10.12200/j.issn.1003-0034.2022.05.011.
8
Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study.硫酸软骨素和氨基葡萄糖联合使用可降低人骨关节炎软骨下骨成骨细胞的促吸收特性:一项基础科学研究。
Arthritis Res Ther. 2007;9(6):R117. doi: 10.1186/ar2325.
9
Pathological progression of osteoarthritis: a perspective on subchondral bone.骨关节炎的病理进展:对软骨下骨的认识。
Front Med. 2024 Apr;18(2):237-257. doi: 10.1007/s11684-024-1061-y. Epub 2024 Apr 15.
10
New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?骨关节炎的新视角:骨保护素和核因子κB受体活化因子配体系统作为潜在治疗靶点?
Keio J Med. 2009 Mar;58(1):29-40. doi: 10.2302/kjm.58.29.

引用本文的文献

1
Current progress of plant-derived exosome-like nanovesicles on the regulation of osteoporosis and osteoarthritis.植物源外泌体样纳米囊泡在骨质疏松症和骨关节炎调控方面的研究进展
Ann Med. 2025 Dec;57(1):2549524. doi: 10.1080/07853890.2025.2549524. Epub 2025 Aug 22.
2
Subchondral injection of human umbilical cord mesenchymal stem cells ameliorates knee osteoarthritis by inhibiting osteoblast apoptosis and TGF-beta activity.人脐带间充质干细胞的软骨下注射通过抑制成骨细胞凋亡和转化生长因子-β活性改善膝骨关节炎。
Stem Cell Res Ther. 2025 May 9;16(1):235. doi: 10.1186/s13287-025-04366-7.
3
Interleukin 26 attenuates osteoblast differentiation in osteoarthritis patients by activating COX2 and NF-κB pathways.
白细胞介素26通过激活COX2和NF-κB信号通路减弱骨关节炎患者的成骨细胞分化。
Int J Med Sci. 2025 Feb 26;22(7):1504-1515. doi: 10.7150/ijms.102967. eCollection 2025.
4
The Presentation, Clinical Diagnosis, Risk Factors, and Management of Rapidly Progressive Hip Osteoarthritis: A Narrative Literature Review.快速进展性髋骨关节炎的临床表现、临床诊断、危险因素及管理:一项叙述性文献综述
J Clin Med. 2024 Oct 17;13(20):6194. doi: 10.3390/jcm13206194.
5
TRPV Channels in Osteoarthritis: A Comprehensive Review.TRPV 通道在骨关节炎中的作用:全面综述。
Biomolecules. 2024 Feb 29;14(3):292. doi: 10.3390/biom14030292.